A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03625505 · COMPLETED
Trial details
- NCT number
- NCT03625505
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-18
- Primary completion
- 2021-08-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.